Concepedia
Statistics
Publications
70
Citations
3.2K
H-Index
28
Active since
2004
Affiliations
Keimyung University(Current)
Keimyung University Dongsan Medical Center
University of Ulsan
Chonnam National University Hwasun Hospital
Asan Medical Center
Young Rok is an author at Keimyung University specializing in medicine, pathology, and oncology.
Top concepts
MedicineOncologyPathologyRadiation OncologyImmunologyHealthHematologyImmunotherapyCancer TherapyCancer Research
Publications per year
2004–2024
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
Catherine Thiéblemont, Tycel Phillips, Hervé Ghesquières et al. · Journal of Clinical Oncology · 2022 · 484 citations · Full text
Experiences and Attitudes of Patients With Terminal Cancer and Their Family Caregivers Toward the Disclosure of Terminal Illness
Young Ho Yun, Yong Chol Kwon, Myung Kyung Lee et al. · Journal of Clinical Oncology · 2010 · 146 citations · Full text
Family Medicine, Terminal Status, Cancer Patients +18
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Yu Ri Kim, Jin Seok Kim, Yoo Hong Min et al. · Journal of Hematology & Oncology · 2012 · 97 citations · Full text
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Catherine Thiéblemont, Yasmin Karimi, Hervé Ghesquières et al. · Leukemia · 2024 · 87 citations · Full text
1–5 of 70